Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

Technology appraisal guidance
Reference number: TA225
Published: 22 June 2011

TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: Appendix A provisional matrix of stakeholders

TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: Appendix A provisional matrix of stakeholders

TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: Appendix A provisional matrix of stakeholders
15 July 2013
(42.26 Kb 12 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 July 2013